Posmodernidad, sociedades adictivas, cannabis y comportamiento suicida¿hacia un mundo feliz?

Referencias bibliográficas

• WHO. (2014). Preventing suicide: A global imperative. Ginebra: World Health Organization.
• Agrawal, A., Nelson, E. C., Bucholz, K. K., Tillman, R., Grucza, R. A., Statham, D. J.,… Lynskey, M. T. (2017). Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study. Lancet Psychiatry, 4, 706-714. doi:10.1016/S2215-0366(17)30280-8.
• Alvarez, A., Gamella, J. F. y Parra, I. (2017). The legalization of cannabis derivatives in Spain: Hypothesis on a potential emerging market. Adicciones, 29, 195-206. doi:10.20882/adicciones.807.
• Bilkei-Gorzo, A., Albayram, O., Draffehn, A., Michel, K., Piyanova, A., Oppenheimer, H.,… Zimmer, A. (2017). A chronic low dose of Delta9-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nature Medicine, 23, 782-787. doi:10.1038/nm.4311.
• Blasco-Fontecilla, H. (2012). The addictive hypothesis of suicidal behavior. Medical Hypotheses, 78, 350. doi:10.1016/j.mehy.2011.11.005.
• Blasco-Fontecilla, H. (2014). Medicalization, wish-fulfilling medicine, and disease mongering: toward a brave new world? Revista Clinica Española, 214, 104-107.
• Blasco-Fontecilla, H. (2017). Hacia un mundo feliz. Madrid: Libros.com.
• Blasco-Fontecilla, H., Artieda-Urrutia, P., Berenguer-Elias, N., Garcia-Vega, J. M., Fernandez-Rodriguez, M., Rodriguez-Lomas, C.,… de Leon, J. (2014). Are major repeater patients addicted to suicidal behavior? Adicciones, 26, 321-333.
• Blasco-Fontecilla, H., Baca-García, E., Courtet, P., García Nieto, R. y de Leon, J. (2015). Horror Vacui: Emptiness Might Distinguish between Major Suicide Repeaters and Nonmajor Suicide Repeaters: A Pilot Study. Psychotheraphy and Psychosomatics, 84, 117-119.
• Blasco-Fontecilla, H., Fernandez-Fernandez, R., Colino, L., Fajardo, L., Perteguer-Barrio, R. y de Leon, J. (2016). The Addictive Model of Self-Harming (Non-suicidal and Suicidal) Behavior. Frontiers in Psychiatry, 7, 8. doi:10.3389/fpsyt.2016.00008.
• Casajuana, C., Lopez-Pelayo, H., Balcells, M. M., Colom, J. y Gual, A. (2017). Psychoactive constituents of cannabis and their clinical implications: a systematic review. Adicciones, Avance de publicación on-line. doi:10.20882/adicciones.858.
• Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H. y Astrup, A. (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet, 370, 1706-1713.
• Claudet, I., Mouvier, S., Labadie, M., Manin, C., Michard-Lenoir, A. P., Eyer, D. y Dufour, D. (2017). Unintentional Cannabis Intoxication in Toddlers. Pediatrics, 140, e20170017. doi:10.1542/peds.2017-0017.
• Colino L, Herranz-Herrer, J., Gil-Benito E, Ponte-Lopez T, del Sol-Calderon P, Rodrigo-Yanguas M,… Blasco-Fontecilla H (en prensa). Cannabinoid receptors, mental pain and suicidal behavior: a systematic review. Current Psychiatry Reports.
• Czernin, S., Vogel, M., Fluckiger, M., Muheim, F., Bourgnon, J. C., Reichelt, M.,… Stoppe, G. (2012). Cost of attempted suicide: a retrospective study of extent and associated factors. Swiss Medical Weekly, 142, w13648. doi:10.4414/smw.2012.13648.
• de Leon, J., Baca-Garcia, E. y Blasco-Fontecilla, H. (2015). From the serotonin model of suicide to a mental pain model of suicide. Psychotheraphty and Psychosomatics, 84, 323-329. doi:10.1159/000438510.
• Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R.,… Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 376, 2011-2020. doi:10.1056/NEJMc1708349.
• El Marroun, H., Hudziak, J. J., Tiemeier, H., Creemers, H., Steegers, E. A., Jaddoe,… Huizink, A. C. (2011). Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug and Alcohol Dependence, 118, 470-474. doi:10.1016/j.drugalcdep.2011.03.004.
• El Marroun, H., Tiemeier, H., Franken, I. H., Jaddoe, V. W., van der Lugt, A., Verhulst, F. C.,… White, T. (2016). Prenatal Cannabis and Tobacco Exposure in Relation to Brain Morphology: A Prospective Neuroimaging Study in Young Children. Biological Psychiatry, 79, 971-979. doi:10.1016/j.biopsych.2015.08.024.
• Etges, T., Karolia, K., Grint, T., Taylor, A., Lauder, H., Daka, B. y Wright, S. (2016). An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray. Therapeutics and Clinical Risk Management, 12, 1667-1675.
• Freeman, D., Dunn, G., Murray, R. M., Evans, N., Lister, R., Antley, A.,… Morrison, P. D. (2015). How cannabis causes paranoia: using the intravenous administration of 9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia. Schizophrenia Bulletin, 41, 391-399. doi:10.1093/schbul/sbu098.
• Freeman, T. P. y Winstock, A. R. (2015). Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine, 45, 3181-3189. doi:10.1017/S0033291715001178.
• Garcia del Pozo, J., Carvajal, A., Viloria, J. M., Velasco, A. y Garcia del Pozo, V. (2008). Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. European Journal of Clinical Pharmacology, 64, 411-415.
• Hasin, D. S., Sarvet, A. L., Cerda, M., Keyes, K. M., Stohl, M., Galea, S. y Wall, M. M. (2017). US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74, 579-588. doi:10.1001/jamapsychiatry.2017.0724.
• Hauser, W., Petzke, F. y Fitzcharles, M. A. (2017). Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews. European Journal of Pain. Avance de publicación on-line. doi:10.1002/ejp.1118. doi: 10.1002/ejp.1118.
• Huizenga, M. N., Wicker, E., Beck, V. C. y Forcelli, P. A. (2017). Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats. Epilepsia, 58, 1593-1602. doi:10.1111/epi.13842.
• Hurd, Y. L. (2017). Cannabidiol: Swinging the Marijuana Pendulum From ‘Weed’ to Medication to Treat the Opioid Epidemic. Trends in Neurosciences, 40, 124-127. doi:10.1016/j.tins.2016.12.006.
• Kaplan, E. H., Offermann, E. A., Sievers, J. W. y Comi, A. M. (2017a). Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome. Pediatric Neurology, 71, 18-23 e2. doi:10.1016/j.pediatrneurol.2017.02.009.
• Kaplan, J. S., Stella, N., Catterall, W. A. y Westenbroek, R. E. (2017b). Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. Proceedings of the National Academy of Sciences of the United States of America, 114, 11229-11234. doi:10.1073/pnas.1711351114.
• Lipovetsky, G. (1986). La era del vacío. Barcelona: Anagrama.
• Manrique-Garcia, E., Ponce de Leon, A., Dalman, C., Andreasson, S. y Allebeck, P. (2016). Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men. American Journal of Psychiatry, 173, 790-798. doi:10.1176/appi.ajp.2016.14050637.
• Meier, M. H., Caspi, A., Cerda, M., Hancox, R. J., Harrington, H., Houts, R.,… Moffitt, T. E. (2016). Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users. JAMA Psychiatry, 73, 731-740. doi:10.1001/jamapsychiatry.2016.0637.
• Murray, R. M., Englund, A., Abi-Dargham, A., Lewis, D. A., Di Forti, M., Davies, C.,… D’Souza, D. C. (2017). Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology, 124, 89-104. doi:10.1016/j.neuropharm.2017.06.018.
• Murthy, V. H. (2016). Ending the Opioid Epidemic - A Call to Action. The New England Journal of Medicine, 375, 2413-2415. doi:10.1056/NEJMp1612578.
• Rego, P. (2017). Vuelven los zombis (de la heroína). En: El mundo: España. Recuperado de http://www.elmundo.es/cronica/2017/11/09/59ff451fe5fdea662c8b45be.html.
• Riba, J., Valle, M., Sampedro, F., Rodriguez-Pujadas, A., Martinez-Horta, S., Kulisevsky, J. y Rodriguez-Fornells, A. (2015). Telling true from false: cannabis users show increased susceptibility to false memories. Molecular Psychiatry, 20, 772-777. doi:10.1038/mp.2015.36.
• Rigucci, S., Marques, T. R., Di Forti, M., Taylor, H., Dell’Acqua, F., Mondelli, V.,… Dazzan, P. (2016). Effect of high-potency cannabis on corpus callosum microstructure. Psychological Medicine, 46, 841-854. doi:10.1017/S0033291715002342.
• Ruehle, S., Rey, A. A., Remmers, F. y Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. Journal of Psychopharmacology, 26, 23-39. doi:10.1177/0269881111408958.
• Russo, M., Naro, A., Leo, A., Sessa, E., D’Aleo, G., Bramanti, P. y Calabro, R. S. (2016). Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis. Pain Medicine, 17, 1145-1154. doi:10.1093/pm/pnv080.
• Saiz, P. A. y Bobes, J. (2014). Suicide prevention in Spain: An uncovered clinical need. Revista de Psiquiatría y Salud Mental, 7, 1-4. doi:10.1016/j.rpsm.2014.01.003.
• Schoeler, T., Petros, N., Di Forti, M., Klamerus, E., Foglia, E., Murray, R. y Bhattacharyya, S. (2017). Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry, 4, 627-633. doi:10.1016/S2215-0366(17)30233-X.
• Schoeler, T., Petros, N., Di Forti, M., Pingault, J. B., Klamerus, E., Foglia, E., … y Bhattacharyya, S. (2016). Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study. JAMA Psychiatry, 73, 1173-1179. doi:10.1001/jamapsychiatry.2016.2427.
• Sophocleous, A., Robertson, R., Ferreira, N. B., McKenzie, J., Fraser, W. D. y Ralston, S. H. (2017). Heavy Cannabis Use Is Associated With Low Bone Mineral Density and an Increased Risk of Fractures. American Journal of Medicine, 130, 214-221.
• Tedesco, D., Asch, S. M., Curtin, C., Hah, J., McDonald, K. M., Fantini, M. P. y Hernandez-Boussard, T. (2017). Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges. Health Affairs (Millwood), 36, 1748-1753. doi:10.1377/hlthaff.2017.0260.
• Walsh, Z., Gonzalez, R., Crosby, K., M, S. T., Carroll, C. y Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A guided systematic review. Clinical Psychological Review, 51, 15-29. doi:10.1016/j.cpr.2016.10.002.
• WHO (1999). Figures and facts about suicide. Ginebra: World Health Organization.
• Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R.,… Guimaraes, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Pharmaceutical Design, 18, 5131-5140.
• Zuil, M., Pascual, A. (2017). Tu madre también se droga (pero con receta). En: El Confidencial: Madrid. Recuperado de https://www.elconfidencial.com/espana/2017-01-22/opioides-ansioliticos-tramadol-oxycontin-alprazolam-diazepam-benzodiacepinas_1319536/